IL-2 Treatment ServicesBaton Rouge General's Pennington Cancer Center has developed a regionally recognized cancer program with a highly skilled, interdisciplinary team of caregivers, trained and dedicated specifically to the care of patients undergoing IL-2 therapy.
Our inpatient center includes spacious, private rooms appointed with wood floors, microwave, refrigerator and television. Newly added space for family members offers quiet accommodations for resting, reading or consulting with your loved one's team of caregivers. Our campus amenities include free valet parking, a full-service café, courtyards, coffee shop, pharmacy and gift shop.
For more information on how to receive IL-2 treatment at Baton Rouge General or for help getting hotel accommodations, please call (225) 237-1600 to speak to our patient navigator.
Baton Rouge General’s regionally recognized IL-2 cancer treatment program is led by medical director Dr. Gerald Miletello. One of the most experienced IL-2 oncologists in the nation, Dr. Miletello has treated patients with IL-2 therapy since 2001. In his more than 25-year practice, Dr. Miletello’s outcomes with IL-2 therapy have surpassed the national averages and he has seen many success stories in his ten years of administering IL-2 for treatment of metastatic melanoma and metastatic kidney cancer.
Dr. Miletello is Board Certified in Internal Medicine and Medical Oncology and is a graduate of Louisiana State University's School of Medicine in New Orleans. In addition to seeing patients at the Hematology Oncology Clinic, Dr. Miletello also serves as a member of the East Baton Rouge Parish Medical Society, Southern Medical Association, American College of Physicians and American Society of Clinical Oncology.
Leading Edge Cancer Treatment Close to Home
“At 40 years old, I was diagnosed with metastatic kidney cancer... A farmer, a father, husband and hunter, I had too much to live for. So I saw a cancer specialist in Texas, and he advised I come home to Baton Rouge General’s Pennington Cancer Center for IL-2 treatment. Thanks to my team at the General, I am cancer-free and looking at a long life in front of me.
I wish my doctor and my nurses could be treated by themselves, just so they’d know how special they really are.”
– JK Bordelon
Hear more stories from IL-2 patients: